Microvascular Phenotyping in The Maastricht Study: Design, and Main findings, 2010-2018. Li, W., Schram, M. T., Sorensen, B. M., Agtmaal, M. J. M., Berendschot, T., Webers, C. A. B., Jansen, J. F. A., Backes, W. H., Gronenschild, E., Schalkwijk, C. G., Stehouwer, C. D. A., & Houben, A. Am J Epidemiol, 2020. Li, Wenjie Schram, Miranda T Sorensen, Ben M Agtmaal, Marnix J M Berendschot, Tos T J M Webers, Carroll A B Jansen, Jacobus F A Backes, Walter H Gronenschild, Ed H B M Schalkwijk, Casper G Stehouwer, Coen D A Houben, Alfons J H M eng 2020/02/23 06:00 Am J Epidemiol. 2020 Feb 20. pii: 5741087. doi: 10.1093/aje/kwaa023.
Microvascular Phenotyping in The Maastricht Study: Design, and Main findings, 2010-2018 [link]Paper  doi  abstract   bibtex   
Microvascular dysfunction (MVD) is a common pathophysiological change in various diseases, such as type 2 diabetes mellitus (T2DM), heart failure, dementia and depression. Recent technical advances enable the measurement and quantification of microvascular changes non-invasively in humans. In this paper, we describe the protocols of the microvascular measurements applied in The Maastricht Study, an ongoing prospective population-based cohort study, which includes a variety of non-invasive measurements in skin, retina, brain, and sublingual tissue as well as plasma and urine biomarker assessments. Following this, we summarize our main findings involving these microvascular measurements up to 2018. Finally, we provide a brief perspective of future microvascular investigations, within the framework of The Maastricht Study.
@article{RN230,
   author = {Li, W. and Schram, M. T. and Sorensen, B. M. and Agtmaal, M. J. M. and Berendschot, Ttjm and Webers, C. A. B. and Jansen, J. F. A. and Backes, W. H. and Gronenschild, Ehbm and Schalkwijk, C. G. and Stehouwer, C. D. A. and Houben, Ajhm},
   title = {Microvascular Phenotyping in The Maastricht Study: Design, and Main findings, 2010-2018},
   journal = {Am J Epidemiol},
   note = {Li, Wenjie
Schram, Miranda T
Sorensen, Ben M
Agtmaal, Marnix J M
Berendschot, Tos T J M
Webers, Carroll A B
Jansen, Jacobus F A
Backes, Walter H
Gronenschild, Ed H B M
Schalkwijk, Casper G
Stehouwer, Coen D A
Houben, Alfons J H M
eng
2020/02/23 06:00
Am J Epidemiol. 2020 Feb 20. pii: 5741087. doi: 10.1093/aje/kwaa023.},
   abstract = {Microvascular dysfunction (MVD) is a common pathophysiological change in various diseases, such as type 2 diabetes mellitus (T2DM), heart failure, dementia and depression. Recent technical advances enable the measurement and quantification of microvascular changes non-invasively in humans. In this paper, we describe the protocols of the microvascular measurements applied in The Maastricht Study, an ongoing prospective population-based cohort study, which includes a variety of non-invasive measurements in skin, retina, brain, and sublingual tissue as well as plasma and urine biomarker assessments. Following this, we summarize our main findings involving these microvascular measurements up to 2018. Finally, we provide a brief perspective of future microvascular investigations, within the framework of The Maastricht Study.},
   keywords = {Cardiovascular disease
Microvascular dysfunction
Pathophysiology
Population-based
Type 2 diabetes},
   ISSN = {1476-6256 (Electronic)
0002-9262 (Linking)},
   DOI = {10.1093/aje/kwaa023},
   url = {http://www.ncbi.nlm.nih.gov/pubmed/32077474
https://academic.oup.com/aje/article-abstract/doi/10.1093/aje/kwaa023/5741087?redirectedFrom=fulltext
https://academic.oup.com/aje/advance-article-abstract/doi/10.1093/aje/kwaa023/5741087?redirectedFrom=fulltext},
   year = {2020},
   type = {Journal Article}
}

Downloads: 0